News
-
LNA SANTE : 2024 half-year results
-
Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
-
Capital increase following the allocation of free shares to EuropaCorp employees
-
LNA SANTE : Résultats semestriels 2024
-
Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.
-
Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
-
Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
-
New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
-
Falcon Commences Drilling At Its Great Burnt Copper Project, NL
-
Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
-
EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
-
BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
-
EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share